Contineum Therapeutics, Inc.
CTNM
$11.43
-$0.10-0.87%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.26M | 5.12M | 4.43M | 4.32M | 4.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.90M | 17.12M | 14.93M | 17.90M | 18.11M |
| Operating Income | -16.90M | -17.12M | -14.93M | -17.90M | -18.11M |
| Income Before Tax | -14.46M | -15.16M | -12.79M | -16.04M | -15.99M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.46M | -15.16M | -12.79M | -16.04M | -15.99M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.46M | -15.16M | -12.79M | -16.04M | -15.99M |
| EBIT | -16.90M | -17.12M | -14.93M | -17.90M | -18.11M |
| EBITDA | -16.82M | -17.03M | -14.85M | -17.82M | -18.03M |
| EPS Basic | -0.39 | -0.49 | -0.46 | -0.62 | -0.62 |
| Normalized Basic EPS | -0.24 | -0.31 | -0.28 | -0.39 | -0.39 |
| EPS Diluted | -0.39 | -0.49 | -0.46 | -0.62 | -0.62 |
| Normalized Diluted EPS | -0.24 | -0.31 | -0.28 | -0.39 | -0.39 |
| Average Basic Shares Outstanding | 37.34M | 30.86M | 28.12M | 25.90M | 25.87M |
| Average Diluted Shares Outstanding | 37.34M | 30.86M | 28.12M | 25.90M | 25.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |